Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.
Chen HY, Zhao W, Na'ara S, Gleber-Netto FO, Xie T, Ali S, Thompson ZM, Buell J, Stafford H, Nagarajan P, Davies M, Wong MK, Migden MR, Sharma P, Myers JN, Gross ND, Amit M.
Chen HY, et al. Among authors: stafford h.
JCO Precis Oncol. 2023 Jun;7:e2200490. doi: 10.1200/PO.22.00490.
JCO Precis Oncol. 2023.
PMID: 37285560
Free PMC article.